Deraphar SRL

1.9 FTE

Company number (CBE) 0439.109.003 · VAT BE0439109003

9060 Zelzate

active in Retail sale of pharmaceutical products (NACE 47730)

operating since 04 Dec 1989 (≈ 37 yrs)

Ask Idonis

＋ Add to a list Export to Excel Pro

Public Public page: latest year only. The score, history and details open with a free account. Create a free account

Idonis solidity score

EDCBA

The score of Deraphar shows with a free account.

See the score

Profile

SRL Micro · 1.9 FTE since 1989

Components

Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register

Position in its sectorvs peers
Supplier creditat 30 d
Borrowing capacityborrowable
Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−88,165 €

Equity270,143 €

Cash60,739 €

EBITDA−28,668 €

Total assets778,926 €

Headcount (avg FTE)1.9

Solvency34.7%

The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity -21 % Total assets -37 % Headcount (avg FTE) -21 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Deraphar's annual accounts

	2025	2024	2023	2022	2021
Net result	−88,165 €
Equity	270,143 €
Cash	60,739 €
EBITDA	−28,668 €
Total assets	778,926 €

See all 10 years Export to Excel Pro

Filed annual accounts

Year ended 31 Dec 2025filed on 24 Jul 2026
Year ended 31 Dec 2024filed on 18 Jul 2025
Year ended 31 Dec 2023filed on 17 Jul 2024
Year ended 31 Dec 2022filed on 06 Jul 2023
Year ended 31 Dec 2021filed on 21 Jun 2022

Deraphar's financial analysis

Open the full analysis

Management and control of Deraphar

2 active director(s) in the register.

Deraphar's shareholders and holdings →

See the directors and their mandates

Deraphar's publications in the Belgian Gazette

Read the publications in detail

Company number, VAT number and registered office

Company number (CBE): 0439.109.003
VAT number: BE0439109003
Peppol: Registered · 0208:0439109003 · as of 10 Nov 2026
Legal form: SRL
Incorporated: 04 Dec 1989
Registered office: 9060 Zelzate
Size: Micro · 1.9 FTE
Latest accounts: 2025 · filed on 24 Jul 2026
Activity: Retail sale of pharmaceutical products (NACE 47730)

Deraphar (SRL) has been based in Zelzate since 1989, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 88,165 € and equity of 270,143 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.7%, below the median of its sector (44.2%).

Companies similar to Deraphar

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Deraphar

What is the revenue of Deraphar?

Deraphar files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Deraphar?

In Belgium, the VAT number is the company number prefixed with BE: BE0439109003 for Deraphar, if the company is VAT-registered. Its company number (CBE) is 0439.109.003.

Where is the registered office of Deraphar?

According to the CBE register, the registered office of Deraphar is in 9060 Zelzate.

What is the equity of Deraphar?

At the close of the 2025 financial year, the equity of Deraphar amounts to 270,143 €, a solvency of 34.7% of total assets.

How many people work at Deraphar?

1.9 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Deraphar?

The register lists 2 active mandates at Deraphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Deraphar

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →

Free account in 30 seconds, by email. No bank card.

Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 25 Jul 2026

	Free	Pro	Enterprise
Ask
Analyses per month	≈ 6	≈ 160	≈ 100 per user, pooled
Credit packs (no expiry)	✓	✓	✓
Unit of account	Your account is debited in credits: one analysis ≈ 25 credits, a pack of 1 000 credits ≈ 40 analyses. The exact balance is in your account, the cost of each answer under it.
The company file
Search by name, CBE number or address	✓	✓	✓
Identity, activity, legal status, published mandates	✓	✓	✓
Idonis Score explained (formula and values)	✓	✓	✓
Annual accounts	last 2 financial years	every filed year	every filed year
Ratios	5 basic	all, with provenance	all, with provenance
Indicative supplier credit and borrowing capacity	—	✓	✓
Estimates (revenue, margins, cash flow)	—	✓	✓
Sector positioning on the company file	—	✓	✓
Indicative valuation (range)	—	✓	✓
Deeds published in the Belgian Gazette	last 12 months	full published history	full published history
Follow
Company lists	1 list of 5	multiple lists	multiple · shared
Dashboard signals (filings, Gazette, score)	✓	✓	✓
E-mail alerts	—	✓	✓
Import of a list of company numbers	—	✓	✓
Understand
Explorer: filters, map	50 results	200 per page	200 per page
Sector pages (medians, comparison)	✓	✓	✓
Excel export (auditable formulas)	—	✓	✓
Network
Directors, mandates and people	—	✓	✓
Ownership graph	1 hop	multi-hop, as of a date	multi-hop, as of a date
Team
Users, admin console, usage per person	—	—	✓
Pooled credits, single invoice	—	—	✓
Shared lists	—	—	✓
Integration
API	—	—	optional
Idonis inside your own AI (MCP)	—	—	optional